Table 2.
Estimated EQ-5D least-squares mean utility scores over time by age group
| 50–59 YOA N = 137 |
60–64 YOA N = 90 |
65–69 YOA N = 100 |
70–79 YOA N = 158 |
≥ 80 YOA N = 60 |
Overall ≥ 50 YOA N = 545 |
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | Mean | SE | n | Mean | SE | n | Mean | SE | N | Mean | SE | n | Mean | SE | n | Mean | SE | ||
| All patients with HZ (n = 545) | |||||||||||||||||||
| Day 0 | 69 | 0.670 | 0.037 | 52 | 0.706 | 0.043 | 48 | 0.700 | 0.044 | 91 | 0.671 | 0.032 | 39 | 0.494 | 0.050 | 299 | 0.661 | 0.018 | |
| Day 15 | 49 | 0.814 | 0.036 | 40 | 0.728 | 0.041 | 47 | 0.795 | 0.038 | 69 | 0.689 | 0.031 | 25 | 0.638 | 0.052 | 230 | 0.740 | 0.017 | |
| Day 30 | 108 | 0.875 | 0.023 | 81 | 0.835 | 0.027 | 86 | 0.851 | 0.026 | 131 | 0.759 | 0.021 | 47 | 0.694 | 0.036 | 453 | 0.811 | 0.012 | |
| Day 60 | 114 | 0.921 | 0.021 | 78 | 0.892 | 0.025 | 90 | 0.898 | 0.024 | 141 | 0.831 | 0.019 | 48 | 0.709 | 0.032 | 471 | 0.864 | 0.011 | |
| Day 90 | 107 | 0.914 | 0.021 | 73 | 0.855 | 0.025 | 81 | 0.889 | 0.024 | 132 | 0.892 | 0.019 | 48 | 0.752 | 0.031 | 441 | 0.876 | 0.010 | |
| Day 0–30a | 0.787 | 0.023 | 0.756 | 0.027 | 0.782 | 0.027 | 0.706 | 0.021 | 0.609 | 0.034 | 0.738 | 0.012 | |||||||
| Disutility (day 0–30)b | 0.127 | 0.099 | 0.107 | 0.186 | 0.143 | 0.138 | |||||||||||||
| QALY loss (day 0–30)c | 0.010 | 0.008 | 0.009 | 0.015 | 0.012 | 0.011 | |||||||||||||
| Patients without PHN (n = 520) | |||||||||||||||||||
| Day 0 | 66 | 0.677 | 0.038 | 48 | 0.708 | 0.044 | 45 | 0.726 | 0.045 | 86 | 0.671 | 0.033 | 33 | 0.512 | 0.054 | 278 | 0.671 | 0.019 | |
| Day 15 | 49 | 0.817 | 0.035 | 36 | 0.767 | 0.042 | 45 | 0.802 | 0.038 | 64 | 0.716 | 0.031 | 22 | 0.642 | 0.054 | 216 | 0.759 | 0.017 | |
| Day 30 | 105 | 0.876 | 0.023 | 77 | 0.859 | 0.027 | 83 | 0.859 | 0.026 | 126 | 0.764 | 0.021 | 41 | 0.729 | 0.037 | 432 | 0.823 | 0.012 | |
| Day 60 | 111 | 0.924 | 0.021 | 72 | 0.901 | 0.026 | 87 | 0.905 | 0.024 | 136 | 0.838 | 0.019 | 42 | 0.714 | 0.034 | 448 | 0.871 | 0.011 | |
| Day 90 | 105 | 0.917 | 0.020 | 67 | 0.872 | 0.025 | 77 | 0.903 | 0.023 | 127 | 0.899 | 0.018 | 42 | 0.771 | 0.032 | 418 | 0.888 | 0.010 | |
| Day 0–30a | 0.790 | 0.023 | 0.778 | 0.028 | 0.796 | 0.027 | 0.717 | 0.021 | 0.627 | 0.036 | 0.751 | 0.012 | |||||||
| Disutility (day 0–30)b | 0.127 | 0.094 | 0.107 | 0.182 | 0.144 | 0.137 | |||||||||||||
| QALY loss (day 0–30)c | 0.010 | 0.008 | 0.009 | 0.015 | 0.012 | 0.011 | |||||||||||||
EQ-5D EuroQoL-5 Dimension questionnaire, HZ herpes zoster, N total number of patients in each age group, n number of patients with evaluable questionnaires, PHN postherpetic neuralgia, QALY quality-adjusted life-year, SE standard error, YOA years of age
aDay 0–30 is the estimated least-squares (LS) mean utility score averaged over days 0–30
bDisutility is calculated using the estimated LS mean values at day 90 as the normal or baseline utility score and using the difference between this and the LS mean utility score averaged over days 0–30
cQALY loss calculated as disutility value multiplied by (length of period in days)/(number of days in year), i.e., 30/365